A carregar...
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
Idarucizumab (Praxbind) is a humanized antibody fragment, that reversibly and with high affinityties up dabigatran (Pradaxa). Anticoagulation reversal is achieved immediately, and with no procoagulant effect. It is administered intravenously and clearance is renal. The main clinical application of i...
Na minha lista:
| Publicado no: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536811/ https://ncbi.nlm.nih.gov/pubmed/31213821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S181806 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|